Riskpilot← Back to searchSign inGet full accessKalevan Lääkärit Oy
OYDissolvedY-tunnus 2430236-1C/O Arvonen Kukkaroniemenkatu 7Medical specialists activities · NACE 8622Est. 20111 employees
Revenue 2025
EUR 74K
-31% vs 2024
EBITDA margin
45.8%
-61% vs 2024
Equity ratio
100.0%
Financial strength
Net profit 2025
EUR 27K
-61% vs 2024
| Revenue | EUR 74K | -31% |
| EBITDA | EUR 34K | -61% |
| Net profit | EUR 27K | -61% |
| Total assets | EUR 83K | -99% |
| Equity | EUR 83K | -99% |
| Employees | 1 | — |
Legal name
Kalevan Lääkärit Oy
Y-tunnus number
2430236-1
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
20. syyskuuta 2011
Share capital
EUR 2 500
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on lastenlääkäripalveluiden tarjoaminen yksityisenä lääkäritoimintana ja ostopalveluna julkiselle terveyshuollolle. Yhtiö myöskin tarjoaa asiakkailleen luentoja ja konsultointiapua lääketieteen alueella.
Address
C/O Arvonen Kukkaroniemenkatu 7
Email
miika.arvonen@fimnet.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 | 30 | 103 | 107 | 74 |
| Staff expenses | −2 | −2 | −3 | −2 | −2 |
| EBITDA | −4 | 20 | 86 | 87 | 34 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −4 | 20 | 86 | 87 | 34 |
| Net financials | −0 | — | −0 | 0 | −0 |
| Profit before tax | −4 | 20 | 86 | 87 | 34 |
| Tax | −0 | 2 | 18 | 18 | 7 |
| Net profit | −4 | 17 | 69 | 69 | 27 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 21 | 28 | 9 337 | 8 552 | 83 |
| Equity | 7 | 24 | 9 002 | 7 165 | 83 |
| Long-term debt | — | — | 0 | 0 | 0 |
| Short-term debt | 14 | 4 | 335 | 1 387 | 0 |
| Total debt | 14 | 4 | 335 | 1 387 | 0 |
EBITDA margin
45.8%
This company
15.8%
Market median
+190% vs market
20212025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20212025
Return on equity
32.4%
This company
18.4%
Market median
+76% vs market
20212025
Net profit margin
36.2%
This company
8.1%
Market median
+347% vs market
20212025
Asset turnover
0.90×
This company
1.12×
Market median
+20% vs market
20212025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
PK Deputy Member | Deputy Member | 2011 |
MK Chief Executive Officer | Chief Executive Officer | 2011 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Kalevan Lääkärit Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Päivi Katariina Arvonen | Deputy Member | 0 companies |
| Miika Kaleva Arvonen | Chief Executive Officer | 0 companies |